Home / Biosimilars

Biosimilars

News

EC approval for adalimumab biosimilar Cyltezo posted 17/11/2017

Germany-based Boehringer Ingelheim Pharmaceuticals (Boehringer) announced on 13 November 2017 that it had received European C...

Adalimumab and trastuzumab biosimilars approved in South Korea posted 17/11/2017

South Korean biosimilars maker Samsung Bioepis announced on 9 November 2017 that it had received marketing approval for its b...

Humira deal could cost CMS US$1.48 billion posted 10/11/2017

The settlement deal made between US-based biotech giant Amgen and pharma giant AbbVie regarding AbbVie’s blockbuster arthriti...

EMA accepts biosimilar pegfilgrastim application from Sandoz posted 03/11/2017

Sandoz, the generics division of Novartis, announced on 27 October 2017 that the regulatory submission for its proposed pegfi...

Novo Nordisk petitions FDA to require clinical trials for Victoza biosimilars posted 27/10/2017

Danish pharmaceutical company Novo Nordisk has asked the US Food and Drug Administration (FDA) to require clinical trials for...

 

Research

Loss of efficacy after switching to biosimilar infliximab in Behcet’s patients posted 17/11/2017

Authors from the Division of Rheumatology at the Hospital of Prato, Italy report on three patients with Behçet’s disease that...

Opportunities and challenges for biosimilars in oncology posted 17/11/2017

The rapid increase in healthcare costs, particularly for cancer drugs, has had a major impact on providers, practices, payers...

Phase III switching data support long-term efficacy and safety of rituximab biosimilar Truxima posted 14/11/2017

Results of a phase III extension study have shown that Celltrion Healthcare’s (Celltrion) rituximab biosimilar (Truxima, CT-P...

Physicochemical and biological characterization study of copy biological tocilizumab posted 14/11/2017

Researchers in China have developed a copy biological of F. Hoffmann-La Roche’s  (Roche) arthritis treatment Actemra (to...

Australian prescribers’ views on biologicals naming and substitution posted 14/11/2017

In a survey of 160 prescribers of biologicals in Australia, over three quarters agreed that the country’s Therapeutic Goods A...

 

General

UK launches campaign to promote research on biosimilars posted 17/11/2017

A new campaign launched by the UK’s National Institute for Health Research (NIHR) aims to unlock the potential benefits of bi...

Biosimilars of infliximab posted 10/11/2017

Last update: 10 November 2017Infliximab is a chimeric monoclonal antibody against tumour necrosis factor alpha (TNF-α)....

Biosimilars of rituximab posted 10/11/2017

Last update: 10 November 2017Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily fo...

Hospira to pay Amgen US$70 million for epoetin alfa patent infringement posted 09/11/2017

US-based injectables specialist Hospira has been ordered to pay Biotech giant Amgen US$70 million in damages regarding a pate...

Similar biotherapeutic products approved and marketed in Latin America posted 09/11/2017

Last update: 10 November 2017Regulation of similar biotherapeutic products in Latin America varies widely among dif...